Retinopatía asociada a distrofia muscular facioescapulohumeral. A propósito de un caso tratado con implante intravítreo de dexametasona y fotocoagulación láser

Q3 Medicine

Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-05-01 DOI:10.1016/j.oftal.2025.01.003

A.B. González Escobar, I.E. Molina Guilabert, R.M. García Herrera, I.M. Baquero Aranda, R. Luque Aranda, J.M. Galván Cano

{"title":"Retinopatía asociada a distrofia muscular facioescapulohumeral. A propósito de un caso tratado con implante intravítreo de dexametasona y fotocoagulación láser","authors":"A.B. González Escobar, I.E. Molina Guilabert, R.M. García Herrera, I.M. Baquero Aranda, R. Luque Aranda, J.M. Galván Cano","doi":"10.1016/j.oftal.2025.01.003","DOIUrl":null,"url":null,"abstract":"<div><div>Facioscapulohumeral muscular dystrophy (FSHMD) is a slowly progressive muscular dystrophy that affects especially the muscles of the face, shoulder girdle and upper arms. It may present extramuscular manifestations such as hearing loss and retinopathy. Up to 75% of patients may show alterations in the retinal vasculature such as vascular tortuosity, microaneurysms, telangiectasias, retinal ischemia and exudation, and in less than 1% of cases it may present as Coats-like syndrome. We present a 40-year-old male with FSHMD who, in an ophthalmologic examination, showed exudative retinopathy in his left eye (LE) with peripheral retinal ischemia treated with laser therapy, and macular edema (ME) treated with intravitreal dexamethasone injection (IDI).</div><div>We would like to emphasize the importance of performing an ophthalmological examination on all patients with FSHMD to rule out associated retinal pathology, and thus prevent loss of visual acuity (VA) with early treatment.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 5","pages":"Pages 283-288"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos De La Sociedad Espanola De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0365669125000048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Facioscapulohumeral muscular dystrophy (FSHMD) is a slowly progressive muscular dystrophy that affects especially the muscles of the face, shoulder girdle and upper arms. It may present extramuscular manifestations such as hearing loss and retinopathy. Up to 75% of patients may show alterations in the retinal vasculature such as vascular tortuosity, microaneurysms, telangiectasias, retinal ischemia and exudation, and in less than 1% of cases it may present as Coats-like syndrome. We present a 40-year-old male with FSHMD who, in an ophthalmologic examination, showed exudative retinopathy in his left eye (LE) with peripheral retinal ischemia treated with laser therapy, and macular edema (ME) treated with intravitreal dexamethasone injection (IDI).

We would like to emphasize the importance of performing an ophthalmological examination on all patients with FSHMD to rule out associated retinal pathology, and thus prevent loss of visual acuity (VA) with early treatment.

查看原文本刊更多论文

与面部肩胛骨肌营养不良相关的视网膜疾病。对于一个用地塞米松静脉植入和激光光凝治疗的病例

面肩肱骨肌营养不良症（FSHMD）是一种缓慢进行性肌肉营养不良症，主要影响面部、肩带和上臂的肌肉。它可能表现为肌肉外表现，如听力丧失和视网膜病变。高达75%的患者可能表现为视网膜血管系统的改变，如血管扭曲、微动脉瘤、毛细血管扩张、视网膜缺血和渗出，不到1%的病例可能表现为coats样综合征。我们报告了一位40岁的男性FSHMD患者，在眼科检查中，他的左眼（LE）出现渗出性视网膜病变，周围视网膜缺血用激光治疗，黄斑水肿（ME）用玻璃体内地塞米松注射（IDI）治疗。我们想强调对所有FSHMD患者进行眼科检查的重要性，以排除相关的视网膜病理，从而通过早期治疗防止视力丧失（VA）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archivos De La Sociedad Espanola De Oftalmologia Medicine-Ophthalmology

CiteScore

1.20

自引率

0.00%

发文量

109

审稿时长

78 days

期刊介绍： La revista Archivos de la Sociedad Española de Oftalmología, editada mensualmente por la propia Sociedad, tiene como objetivo publicar trabajos de investigación básica y clínica como artículos originales; casos clínicos, innovaciones técnicas y correlaciones clinicopatológicas en forma de comunicaciones cortas; editoriales; revisiones; cartas al editor; comentarios de libros; información de eventos; noticias personales y anuncios comerciales, así como trabajos de temas históricos y motivos inconográficos relacionados con la Oftalmología. El título abreviado es Arch Soc Esp Oftalmol, y debe ser utilizado en bibliografías, notas a pie de página y referencias bibliográficas.